Recommendations from the EGAPP Working Group: does genomic profiling to assess type 2 diabetes risk improve health outcomes?

Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review

(2013) Glenn E. Palomaki et al.   GENETICS IN MEDICINE

Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update

(2012) David L. Veenstra et al.   GENETICS IN MEDICINE

Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program

(2010) K. A. Jablonski et al.   DIABETES

Use of genomic profiling to assess risk for cardiovascular disease and identify individualized prevention strategies—A targeted evidence-based review

(2010) Glenn E. Palomaki et al.   GENETICS IN MEDICINE

TCF7L2 rs7903146–macronutrient interaction in obese individuals’ responses to a 10-wk randomized hypoenergetic diet

(2009) Katrine Grau et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Impact of Communicating Familial Risk of Diabetes on Illness Perceptions and Self-Reported Behavioral Outcomes: A randomized controlled trial

(2009) M. Pijl et al.   DIABETES CARE

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

(2009) Steven M Teutsch et al.   GENETICS IN MEDICINE

Whole-grain consumption and transcription factor-7-like 2 ( TCF7L2) rs7903146: gene–diet interaction in modulating type 2 diabetes risk

(2008) Eva Fisher et al.   BRITISH JOURNAL OF NUTRITION

Extension of Type 2 Diabetes Genome-Wide Association Scan Results in the Diabetes Prevention Program

(2008) A. F. Moore et al.   DIABETES